Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Open Framework Agreement For Pharmaceutical Discounts In Accordance With § 130a Abs.8 Sgb V With The Possibility Of Joining At Any Time, Known As The Admission Model 2026-01. Pharmaceutical Discounts 2026-06-14
Palestine A Framework Agreement For The Purchase And Supply Of Medical Consumables For Brain Catheterization And Interventional Surgery 2026-06-14
Germany Openhouse Biological Discount Contracts 202537 Peginterferon Alfa2a 2026-06-15
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Formoterol + Beclometasone (exclusively Dafo. Ihp, Inhalation), Atc R03ak08 For The Period 01.01.2026 To 31.12.2027 2026-06-15
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For Pharmaceuticals Containing The Active Ingredient Pamidronic Acid (atc Code 2026-06-15
Germany Conclusion Of Non-exclusive Discount Agreements According To §130a Para. 8 Sgb V For Various Active Ingredients/combinations With The Possibility Of Conclusion At Any Time Within The Framework Of The So-called Open House Procedure. 2026-06-15
Germany Conclusion Not Excluding The Discount Agreement For Pharmaceuticals According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Ingredient Betahistine (atc Code According To Who 2026-06-15
Germany Contrast Agent Active Substance Cross-sectional Open House Procedure For The Kv Region Westfalen-lippe 2026-06-15
Germany Openhouse Biological Discount Contracts 202536 Natalizumab (form For Subcutaneous Injection) 2026-06-15
Germany Conclusion Not Excluding The Pharmaceutical Discount Agreement According To § 130a Para. 8 Sgb V By Means Of An Open House Model For The Active Ingredient Alfacalcidol (atc Code According To Who 2026-06-15
Whats app